A multidrug, including voriconazole, resistant oral Candida infection in an AIDS patient effectively treated with echinocandin [6]

Journal of Infection

Volumn 44, Issue 1, 2002, Pages 57-58

  Ostyn, B ^a,b   Noe A ^a,b   Swinne, D ^a   Ieven, M ^b   Colebunders, R ^a,b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; LAMIVUDINE; MICONAZOLE; NYSTATIN; PYRIMETHAMINE; STAVUDINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIFUNGAL ACTIVITY; CANDIDA; CASE REPORT; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG TOLERABILITY; ESOPHAGITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; LETTER; MALE; MULTIDRUG RESISTANCE; THROAT CULTURE; THROMBOCYTOPENIA; THRUSH;

EID: 0036265203     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2001.0919     Document Type: Editorial

References (6)

1. Emergence of Fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection
2. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients
3. Current approaches to diagnosis and treatment of fungal infections in children infected with human immunodeficiency virus
4. Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS
5. A randomized, double-blind multicenter trial of MK-0991 (L743872) versus amphotericin B (AMB) in the treatment of candida oesophagitis in adults
6. Evaluation of the echinocandin antifungal MK-0991 (L-743872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis